John Zhu - Profile and Investment Details

Investor Profile

John Zhu is a Venture Capital, Private Equity Firm based in Shanghai, China with a diverse investment portfolio that includes companies such as Mingly China Growth Fund, GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics, Yiyao, Viela BioKymera Therapeutics, Hua Medicine, Curon Biopharma, NeuSpera Medical, Ultivue, UNITY Biotechnology, AnchorDx, Fulcrum Therapeutics, Grail, Gracell Biotechnologies, Dewpoint Therapeutics, Biokangtai, HiberCell, Engine Biosciences, CStone Pharmaceuticals, Haoxinqing, WiseTek, TCR2, GloriousMed Technology, Brii Biosciences, TScan Therapeutics, IDEAYA Biosciences, ITeos Therapeutics, Lyvgen Biopharma, Fog Pharmaceuticals, . Over time, John Zhu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Zhu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wellness, Women Founded, Healthcare Innovation, Strategic Partnerships, Life Science, Portfolio Management, Medical Technologies, Venture Fundraising, Finance, Biotechnology, Medical Devices, Innovation, Clinical Trials, Health Diagnostics, Medical, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with John Zhu, as their portfolio suggests a familiarity and interest in this area.

Understanding John Zhu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.